I think the market has missed this one. What a huge opportunity for both ALS sufferers and investors. The early data is compelling. FDA approved Relyvrio based on a survival rate of 75% over a year. PAA has had ZERO deaths over an even longer period. If the upcoming data replicates this then FDA approval seems certain. Investors you've got three weeks maximum to grab this opportunity. DYOR
- Forums
- ASX - By Stock
- Ann: Extension Study Begins, Analysis Suggests Survival Benefit
I think the market has missed this one. What a huge opportunity...
-
- There are more pages in this discussion • 165 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $91.22M |
Open | High | Low | Value | Volume |
21.5¢ | 21.5¢ | 20.5¢ | $174.5K | 841.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 458470 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 144453 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 443470 | 0.200 |
7 | 254593 | 0.195 |
12 | 529478 | 0.190 |
23 | 1020957 | 0.185 |
16 | 883831 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 144453 | 3 |
0.215 | 166899 | 3 |
0.220 | 149118 | 3 |
0.230 | 51179 | 1 |
0.240 | 25634 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |